Sustained Homocysteine-Lowering Effect over Time of Folic Acid-Based Multivitamin Therapy in Stroke Patients despite Increasing Folate Status in the Population

Publisher： Karger

E-ISSN： 1421-9786|19|2|110-116

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.19, Iss.2, 2005-02, pp. : 110-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke

By  

Cerebrovascular Diseases, Vol. 13, Iss. 2, 2002-02 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

Homocysteine-Lowering Therapy and Risk of Recurrent Stroke, Myocardial Infarction and Death: The Impact of Age in the VISP Trial

By  

Cerebrovascular Diseases, Vol. 37, Iss. 4, 2014-04 ,pp. : 263-267

Karger

Access to resources Recommend Favorite

Plasma Homocysteine, Cobalamin/Folate Status, and Vascular Disease in a Large Population of Psychogeriatric Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 4, 2006-10 ,pp. : 358-366

Karger

Access to resources Recommend Favorite

Plasma Total Homocysteine Levels in Stroke Patients Screened for the Vitamin Intervention for Stroke Prevention Clinical Trial in the Era of Folate Fortification

By  

Neuroepidemiology, Vol. 26, Iss. 1, 2005-12 ,pp. : 45-51

Karger

Access to resources Recommend Favorite

Homocysteine-Lowering Treatment in Coronary Heart Disease

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 4, 2005-10 ,pp. : 289-295

Bentham Science Publishers

Access to resources Recommend Favorite